These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2309066)
1. Mechanism of clearance of circulating CA19-9 in rats. Adachi M; Sekine T; Umemoto A; Tsukikawa S; Imai K; Yachi A Tumour Biol; 1990; 11(1-2):51-8. PubMed ID: 2309066 [TBL] [Abstract][Full Text] [Related]
2. Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies. Sakahara H; Saga T; Endo K; Kousaka T; Hosono M; Kobayashi H; Shirato M; Konishi J Br J Cancer; 1993 Nov; 68(5):920-5. PubMed ID: 8217607 [TBL] [Abstract][Full Text] [Related]
3. High serum levels of DUPAN2 antigen and CA19-9 in pancreatic cancer: correlation with immunocytochemical localization of antigens in cancer cells. Suzuki Y; Ichihara T; Nakao A; Sakamoto J; Takagi H; Nagura H Hepatogastroenterology; 1988 Jun; 35(3):128-35. PubMed ID: 3042577 [TBL] [Abstract][Full Text] [Related]
4. Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins. Ho JJ; Norton K; Chung YS; Kim YS Oncol Res; 1993; 5(9):347-56. PubMed ID: 7518709 [TBL] [Abstract][Full Text] [Related]
5. Asialoglycoprotein receptor is uninvolved in clearing intact glycoproteins from rat blood. Clarenburg R Am J Physiol; 1983 Mar; 244(3):G247-53. PubMed ID: 6187222 [TBL] [Abstract][Full Text] [Related]
6. Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels. Hirano K; Kawa S; Oguchi H; Kobayashi T; Yonekura H; Ogata H; Homma T J Natl Cancer Inst; 1987 Dec; 79(6):1261-8. PubMed ID: 2447318 [TBL] [Abstract][Full Text] [Related]
7. [Carbohydrate antigens in pleural effusion from patients with lung cancer]. Hiratani K; Sakito O; Mukae H; Morikawa N; Kadota J; Fukushima K; Komori K; Hirota M; Hara K Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):673-8. PubMed ID: 2552211 [TBL] [Abstract][Full Text] [Related]
8. Investigating clearance mechanisms for recombinant activated factor VII in a perfused liver model. Appa R; Theill C; Hansen L; Møss J; Behrens C; Nicolaisen EM; Klausen NK; Christensen MS Thromb Haemost; 2010 Aug; 104(2):243-51. PubMed ID: 20508904 [TBL] [Abstract][Full Text] [Related]
9. Effect of heterogeneity of carcinoembryonic antigen on liver cell membrane binding and its kinetics of removal from circulation. Byrn RA; Medrek P; Thomas P; Jeanloz RW; Zamcheck N Cancer Res; 1985 Jul; 45(7):3137-42. PubMed ID: 4005850 [TBL] [Abstract][Full Text] [Related]
10. Serum concentration and immunohistochemical localization of SPan-1 antigen in pancreatic cancer. A comparison with CA19-9 antigen. Takeda S; Nakao A; Ichihara T; Suzuki Y; Nonami T; Harada A; Koshikawa T; Takagi H Hepatogastroenterology; 1991 Apr; 38(2):143-8. PubMed ID: 1855772 [TBL] [Abstract][Full Text] [Related]
11. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Takada A; Ohmori K; Yoneda T; Tsuyuoka K; Hasegawa A; Kiso M; Kannagi R Cancer Res; 1993 Jan; 53(2):354-61. PubMed ID: 7678075 [TBL] [Abstract][Full Text] [Related]
12. The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. Barnett D; Liu Y; Partyka K; Huang Y; Tang H; Hostetter G; Brand RE; Singhi AD; Drake RR; Haab BB Sci Rep; 2017 Jun; 7(1):4020. PubMed ID: 28642461 [TBL] [Abstract][Full Text] [Related]
13. Cell surface distribution and intracellular fate of asialoglycoproteins: a morphological and biochemical study of isolated rat hepatocytes and monolayer cultures. Zeitlin PL; Hubbard AL J Cell Biol; 1982 Mar; 92(3):634-47. PubMed ID: 6282890 [TBL] [Abstract][Full Text] [Related]
14. CA19-9 epitope a possible marker for MUC-1/Y protein. Akagi J; Takai E; Tamori Y; Nakagawa K; Ogawa M Int J Oncol; 2001 May; 18(5):1085-91. PubMed ID: 11295060 [TBL] [Abstract][Full Text] [Related]
15. [A case of two patients with primary lung cancer secreting CA19-9]. Nagami H; Nohara T; Yamauchi M; Yamada K; Nakase A Nihon Geka Gakkai Zasshi; 1988 Feb; 89(2):292-6. PubMed ID: 2834635 [TBL] [Abstract][Full Text] [Related]
16. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers]. Kataoka A; Yakushiji M Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782 [TBL] [Abstract][Full Text] [Related]
17. [A new carbohydrate antigen CA19-9 associated with malignancies of digestive system. II. Serum levels of CA19-9 in various digestive diseases and their clinical significance]. Yamanaka T; Kitagawa Y; Seki H; Kimura K; Sakurabayashi I; Kawai T Rinsho Byori; 1984 Jul; 32(7):786-92. PubMed ID: 6594536 [No Abstract] [Full Text] [Related]
18. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients. Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823 [TBL] [Abstract][Full Text] [Related]
19. Plasma clearance and organ distribution of native and desialylated rat and human transcortin: species specificity. Hossner KL; Billiar RB Endocrinology; 1981 May; 108(5):1780-6. PubMed ID: 7215299 [TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of type-1 blood group antigens (Lea, Leb, CA19-9) in colorectal cancer--comparison with CEA]. Kiriyama K; Watanabe T; Sakamoto J; Ito K; Akiyama S; Yamauchi M; Takagi H Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):320-30. PubMed ID: 1675759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]